Gene therapy for thyroid cancer: current status and future prospects

Thyroid : Official Journal of the American Thyroid Association
C Spitzweg, John C Morris

Abstract

Despite multimodality treatment for thyroid cancer, including surgical resection, radioiodine therapy, thyrotropin (TSH)-suppressive thyroxine treatment, and chemotherapy/radiotherapy, survival rates have not improved over the last decades. Therefore, development and evaluation of novel treatment strategies, including gene therapy, are urgently needed. A variety of gene therapy approaches have been evaluated for the treatment of follicular cell-derived and medullary thyroid cancer, including corrective gene therapy (p53 restoration, expression of a dominant negative RET mutant), cytoreductive gene therapy (suicide gene/prodrug strategy herpes simplex virus-thymidine kinase [HSV-tk]/ganciclovir, antiangiogenic therapy with endostatin) and immunomodulatory gene therapy (expression of interleukin (IL)-2 and IL-12). Furthermore, cloning of the sodium iodide symporter (NIS) gene has paved the way for the development of a novel cytoreductive gene therapy strategy based on NIS gene transfer followed by the application of radioiodine therapy ((131)I). NIS gene delivery into medullary and follicular cell-derived thyroid cancer cells has been shown to be capable of establishing or restoring radioiodine accumulation and might therefore re...Continue Reading

References

Sep 13, 1996·Biochemical and Biophysical Research Communications·P A SmanikS M Jhiang
Mar 27, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·W M Gallagher, R Brown
Jul 22, 1999·Cancer Immunology, Immunotherapy : CII·M N SolerS Lausson
Apr 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·S ScalaA Fusco
Nov 13, 2001·Gene Therapy·C SpitzwegJ C Morris
Feb 13, 2002·Thyroid : Official Journal of the American Thyroid Association·Anne BolandMichel Perricaudet
Mar 22, 2002·Nature Reviews. Cancer·F McCormick
Jul 12, 2002·European Journal of Nuclear Medicine and Molecular Imaging·T PetrichE Pötter
Oct 5, 2002·The Journal of Clinical Endocrinology and Metabolism·Ryo ImanishiShunichi Yamashita
Oct 23, 2002·Clinical Endocrinology·Christine Spitzweg, John C Morris
Nov 5, 2002·The Journal of Clinical Endocrinology and Metabolism·Luisa BarzonGiorgio Palù
Feb 14, 2003·Lancet·Steven I Sherman
Mar 12, 2003·The Journal of Clinical Endocrinology and Metabolism·Marinella MessinaBruce G Robinson
Mar 22, 2003·Blood·David DingliStephen J Russell
Aug 14, 2003·The Journal of Clinical Endocrinology and Metabolism·Teiji TakedaKiyoshi Hashizume
Aug 14, 2003·The Journal of Clinical Endocrinology and Metabolism·Hyo Kyun ChungMinho Shong
Oct 15, 2003·The Journal of Clinical Endocrinology and Metabolism·Giuseppe PortellaAlfredo Fusco

❮ Previous
Next ❯

Citations

Nov 7, 2013·Molecular Therapy. Nucleic Acids·Geoffrey K GrünwaldChristine Spitzweg
Feb 23, 2007·Nature Clinical Practice. Endocrinology & Metabolism·Martin SchlumbergerJean-Michel Bidart
Jul 21, 2005·Thyroid : Official Journal of the American Thyroid Association·Jamie C Mitchell, Sareh Parangi
Feb 10, 2010·The Oncologist·Christine J O'NeillStan B Sidhu
Sep 2, 2008·Expert Review of Anticancer Therapy·John BuscombeCaroline Witney-Smith
Dec 20, 2007·Expert Review of Molecular Diagnostics·Marina N Nikiforova, Yuri E Nikiforov
Aug 3, 2006·Surgical Oncology Clinics of North America·Ronald J Weigel, I Ross McDougall
Feb 19, 2005·Journal of Surgical Oncology·Derek T Woodrum, Paul G Gauger
Feb 14, 2017·Annual Review of Physiology·Silvia RaveraNancy Carrasco
Sep 25, 2007·Arquivos brasileiros de endocrinologia e metabologia·Denise P Carvalho, Andrea C F Ferreira
Feb 3, 2007·The Lancet Oncology·Eric Baudin, Martin Schlumberger
Oct 17, 2017·Thyroid : Official Journal of the American Thyroid Association·Kathrin A SchmohlChristine Spitzweg
Apr 9, 2014·The Journal of Clinical Endocrinology and Metabolism·Garcilaso Riesco-EizaguirreAntonio De la Vieja
Nov 6, 2009·PLoS Neglected Tropical Diseases·Thomas MüllerMarie Paule Kieny
Jul 14, 2020·Frontiers in Immunology·Chuang XiQuan-Yong Luo
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Silvana LibertiniGiuseppe Portella
Mar 7, 2021·Cancers·Antonio De la Vieja, Garcilaso Riesco-Eizaguirre

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.